Legend Biotech (LEGN) Revenue (2019 - 2025)

Legend Biotech has reported Revenue for 7 years, with the latest figure at $306.3 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue rose 64.24% year-over-year to $306.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (up 64.02% YoY), and the FY2025 full-year result was $1.0 billion, up 64.02% from the prior year.
• Revenue for Q4 2025 stood at $306.3 million, up from $272.3 million in the prior quarter.
• The five-year high for Revenue was $79.5 billion in Q4 2023, with the low at $12.0 million in Q2 2022.
• Historically, Revenue has averaged $4.1 billion across 5 years, with a median of $83.7 million in 2023.
• Annual changes were most pronounced in 2023 — Revenue jumped 287469.21% — and 2024, when it slumped 99.77%.
• Legend Biotech's Revenue stood at $39.0 million in 2021, then retreated by 29.14% to $27.6 million in 2022, then jumped by 287469.21% to $79.5 billion in 2023, then tumbled by 99.77% to $186.5 million in 2024, then soared by 64.24% to $306.3 million in 2025.
• The last three Revenue figures came in at $306.3 million (Q4 2025), $272.3 million (Q3 2025), and $255.1 million (Q2 2025), per Business Quant data.